Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,345.00
+10.00 (0.75%)
At close: Mar 26, 2026
Craneware Market Cap
Craneware has a market cap or net worth of 465.84 million as of March 26, 2026. Its market cap has decreased by -27.70% in one year.
Market Cap
465.84M
Enterprise Value
455.40M
Revenue
157.02M
Ranking
n/a
PE Ratio
28.61
Stock Price
1,345.00
Market Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 465.84M, an increase of 1,625.62%. That is a compound annual growth rate of 16.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 465.84M | -31.18% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.19B |
| GSK plc | 79.07B |
| Haleon | 32.31B |
| Smith & Nephew | 10.28B |
| CVS Group | 806.80M |
| Oxford Biomedica | 732.49M |
| Allergy Therapeutics | 664.92M |
| Spire Healthcare Group | 574.39M |